ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
Abstract MLL-rearranged acute myeloid leukemia (AML) remains a fatal disease with a high rate of relapse and therapeutic failure due to chemotherapy resistance. In analysis of our Affymetrix microarray profiling and chromatin immunoprecipitation (ChIP) assays, we found that ALOX5 is especially down-...
Guardado en:
Autores principales: | Yungui Wang, Jennifer R. Skibbe, Chao Hu, Lei Dong, Kyle Ferchen, Rui Su, Chenying Li, Hao Huang, Hengyou Weng, Huilin Huang, Xi Qin, Jie Jin, Jianjun Chen, Xi Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f693c34a5ab845d5aef3a46dd809a2a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Yue Sheng, et al.
Publicado: (2020) -
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Svetlana S. Itskovich, et al.
Publicado: (2020) -
MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX
por: YANG Rui, et al.
Publicado: (2021) -
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Svetlana S. Itskovich, et al.
Publicado: (2020) -
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Xi Jiang, et al.
Publicado: (2017)